Failure to Obtain and Administer Ordered Medications Timely for Multiple Residents
Summary
The deficiency involves the facility’s failure to follow physician orders and its own policies for medication availability and administration for four of five sampled residents. Facility policies on pain management and medication reordering required a systematic approach to assess and manage pain, obtain medications in a timely manner, and begin new medications within 24 hours unless otherwise specified. The policies also required that stat medications be available through an emergency supply and that pharmaceutical services be provided accurately and safely to meet each resident’s needs. For one resident who returned from the hospital with comfort measures in place, the discharge summary noted that the resident was approved for comfort measures and had highly unstable vital signs. New orders from the hospital included sublingual atropine, lorazepam, and morphine sulfate concentrate to be given every hour as needed for secretions, anxiety, pain, or air hunger. Progress notes documented that on the day of return from the hospital, staff identified that the frequency of comfort kit medications was missing from transition orders, contacted the physician’s office, and were told no nurse or clinician manager was available, and that the pharmacy would not process the orders without the missing information. No new orders were obtained at that time, and the MAR showed that morphine was not provided until the following day. A medication aide reported that the resident was sleeping and did not appear to be in pain, and that family requested round-the-clock morphine, but the comfort kit medications were not available. The DON and Administrator acknowledged that medications were not being delivered consistently and timely for newly admitted or recently hospitalized residents and that the physician had not been notified when medications were unavailable or not dispensed per orders and policy. For another resident admitted in March, the order summary listed multiple scheduled medications for conditions including paroxysmal atrial fibrillation, hypertension, diabetes, hypothyroidism, hypomagnesemia, hypokalemia, chronic pulmonary edema, hyperlipidemia, and GERD, as well as PRN medications for pain and wheezing. The MAR for March showed that many of these medications were either not started on the admission date or not given consistently for several days, including amlodipine, apixaban, atorvastatin, carvedilol, furosemide, hydralazine, Jardiance, levothyroxine, magnesium, metformin, pantoprazole, potassium, valsartan, and an inhaled medication. Progress notes indicated that medications were either not available or the facility was still waiting on them. The resident reported no negative impact from the missed medications. The DON and Administrator again stated they were aware of delays in medication delivery and that the physician had not been notified when medications were not available or administered as ordered. A third resident admitted in April had orders for multiple medications related to VTE history, COPD, chronic pain, diabetes, bipolar disorder, hypotension, allergies, hypokalemia, restless legs syndrome, PTSD-related nightmares, essential tremor, heart failure, and major depressive disorder, as well as an inhaled medication for COPD. The April MAR showed that several medications, including apixaban, empagliflozin, lamotrigine, midodrine, montelukast, potassium, pramipexole, prazosin, primidone, and ziprasidone, were either not started on the admission date or not given consistently until one to two days later. This resident also reported no negative impact from the missed medications. The DON and Administrator reiterated their knowledge of inconsistent and untimely medication delivery and their failure to notify the physician when medications were not available or dispensed per orders and policy. A fourth resident admitted in April had orders for levothyroxine, memantine, ropinirole, and rivaroxaban for hypothyroidism, dementia, restless legs syndrome, and atrial fibrillation. The April MAR showed that levothyroxine and memantine were not provided until two days after admission, and that ropinirole and rivaroxaban were not provided consistently since admission. As with the other residents, the DON and Administrator acknowledged awareness that medications for newly admitted and recently hospitalized residents were not being delivered consistently and timely, and that they had not notified the physician when medications were unavailable or not administered according to physician orders and facility policy.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



